News Conference News EAS 2025 Back From the Brink: Obicetrapib Performs Well in BROADWAY, TANDEM Yael L. Maxwell May 08, 2025
News Daily News Marked LDL Lowering With Obicetrapib in HeFH: BROOKLYN Michael O'Riordan July 29, 2024
News Daily News Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2 Michael O'Riordan June 14, 2023
News Daily News One in Three Premature CV Deaths in Young Adults Tied to Social Vulnerability Yael L. Maxwell February 09, 2023
News Daily News Hypertension and Heavy Coffee Consumption a Bad Combo, Study Finds L.A. McKeown December 29, 2022
News Conference News EAS 2022 ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering Michael O'Riordan May 24, 2022
News Daily News ASCVD Risk in South Asians Far Exceeds Forecasts by Common Scores Shelley Wood July 12, 2021
News Conference News ESC 2019 ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More Shelley Wood August 22, 2019
News Daily News Weight Training, Aerobic Exercise Affect Cardiac Fat Mass in Different Ways Michael O'Riordan July 05, 2019
News Conference News ACC 2018 Precision Medicine Gamble Fails for CETP Inhibitors in ACCELERATE Analysis Michael O'Riordan March 14, 2018